Our Story
This family-founded, research-focussed foundation is being launched by Megan Donnell, mother to two children with an extremely rare disease.
Tragically, Isla (4 years.5) and her little brother Jude (2 years.5) were both recently diagnosed with a fatal genetic disorder called Mucopolysaccharidosis III (MPSIIIA), otherwise known as Sanfilippo Syndrome. Isla was diagnosed in May 2013 and in a devastating blow Jude’s diagnosis came just four weeks later!
There is currently no cure or effective treatment available to Isla and Jude, nor the estimated 40–50 other Australian families affected by Sanfilippo Syndrome, and there are new cases diagnosed every year. The disease has particularly devastating consequences as children lose mobility, speech and develop dementia-like symptoms. Life expectancy is just 12-20 years. Children appear healthy at birth but begin to show signs of the disease onset is typically from the age of five.
But all hope is not lost! Jude and Isla live on the Northern Beaches in Sydney with their parents Allan and Megan, who, tragically both carry the recessive gene for the condition, which occurs in approx. every 70,000 live births in Australia.
Globally, there has been great recent progress made in ground-breaking and pioneering medicalthe area of treatments for patients with Sanfilippo and there is real promise for a cure. It is exciting to also note that these therapies have the potential for a far broader reach of future use in other central nervous system related pathologies, such as Alzheimer’s and Parkinson’s disease. This has been in the pioneering areas of intrathecal enzyme replacement therapy (ERT) and gene therapy. Much of this progress is due to the tireless efforts of foundations and biotech companies established by families—just like ours—with the objective to pioneer treatments within accelerated timeframes.
Unfortunately, there is virtually no access to the established research programs for Australian patients here in the “lucky country”. With your help the Sanfilippo Children’s Foundation aims to enable international collaboration and provide access to life-saving treatments for Australian children affected by this disease. With your help, Megan and Allan hope to raise awareness of Sanfilippo Syndrome in the medical world, wider community and ultimately drive the science towards human trials that will one day lead to a cure.